1371591-87-5

Basic information

• Product Name: tert-butyl 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoate
• Synonyms: tert-butyl 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoate
• CAS NO: 1371591-87-5
• Molecular Weight: 482.552
• Mol File: 1371591-87-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoate(1371591-87-5)
• EPA Substance Registry System: tert-butyl 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoate(1371591-87-5)

Safety Data

• Hazardous Substances Data: 1371591-87-5(Hazardous Substances Data)

Upstream product

• 872018-02-5 tert-butyl 4-cyano-2-fluorobenzoate 
• 164149-28-4 4-cyano-2-fluorobenzoic acid 
• 1371591-78-4 tert-butyl 2-fluoro-4-{5-[(1S)-1-hydroxypropyl]-1,2,4-oxadiazol-3-yl}benzoate 
• 72569-10-9 1-(4-hydroxyphenyl)-2,2-dimethylpropan-1-one 
• 1371591-77-3 tert-butyl 4-{5-[(1S)-1-acetoxypropyl]-1,2,4-oxadiazol-3-yl}-2-fluorobenzoate 
• 630-18-2 tert-butyl isocyanide 
• 6793-92-6 p-benzyloxyphenylbromide 
• 1263483-74-4 tert-butyl 4-amino(hydroxyimino)methyl-2-fluorobenzoate 

Downstream Products

• 1371591-89-7 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoic acid 

Relevant articles and documents

ACYLBENZENE DERIVATIVE

Provided are compounds having an excellent hypoglycemic action and a β cell- or pancreas-protecting action or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.